GILD
Gilead Sciences, Inc.
- Free cash flow, 2025
- $9.5B
- YoY, 2025
- −8.2%
- 5-year CAGR
- +4.7%
Free cash flow
Free cash flow by fiscal year
| Period | Free cash flow | YoY |
|---|---|---|
| 2025 | $9.5B | −8.2% |
| 2024 | $10.3B | +38.9% |
| 2023 | $7.4B | −11.1% |
| 2022 | $8.3B | −22.8% |
| 2021 | $10.8B | +43.7% |
| 2020 | $7.5B | −9.6% |
| 2019 | $8.3B | +11.3% |
| 2018 | $7.5B | — |
| 2013 | $3.0B | — |